Researchers develop and test new treatments for deadly Naegleria fowleri infections
Updated
Updated · Livescience.com · Apr 24
Researchers develop and test new treatments for deadly Naegleria fowleri infections
11 articles · Updated · Livescience.com · Apr 24
Recent studies highlight nitroxoline and elatol as promising alternatives to miltefosine, which helped save a Texas child and two other U.S. patients since 1978.
Miltefosine, now commercially available, remains the main treatment but has toxic side effects and limited global access. Rapid diagnosis and treatment are critical, as the fatality rate exceeds 97%.
Researchers are also exploring mRNA vaccines, while increased awareness and education efforts aim to improve early detection and survival for this rare but devastating disease.
What existing medicines are being repurposed to fight this deadly brain infection?
How can doctors win the diagnostic race against this meningitis-mimicking killer?
Could an mRNA vaccine finally conquer the brain-eating amoeba where drugs have failed?
Can we identify who is genetically vulnerable to this amoeba before they are exposed?
As climate change pushes this deadly amoeba north, are local hospitals prepared for it?
Is a rare genetic flaw the true key to the brain-eating amoeba's deadly power?